The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SPARK, studying pathways of resistance in KRAS-driven cancers: A remote plasma ctDNA participation study to identify mechanisms of resistance to KRAS inhibitors.
 
Biagio Ricciuti
Consulting or Advisory Role - Regeneron
 
Elinton Lee
No Relationships to Disclose
 
Terri Conneran
No Relationships to Disclose
 
Jennifer C. King
Consulting or Advisory Role - Amgen (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squibb (Inst); EQRX (Inst)
Research Funding - Bristol Myers Squibb (Inst); Genentech (Inst)
 
Allison Harper
No Relationships to Disclose
 
Giuseppe Lamberti
No Relationships to Disclose
 
Gifty Brisbane
No Relationships to Disclose
 
Katerina Hoskova
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Travel, Accommodations, Expenses - Foundation Medicine
 
Sarah Clifford
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Jo-Ellen Murphy
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche Pharma AG
Travel, Accommodations, Expenses - Foundation Medicine
 
Richard S.P. Huang
Employment - Roche/Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patent on IHC; provisional patent on biomarkers and biomarker methodology.
 
Geoffrey R. Oxnard
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Anthony Addario
No Relationships to Disclose
 
Richard M. Erwin
Stock and Other Ownership Interests - Selva Therapeutics
Consulting or Advisory Role - IDBiologics; Selva Therapeutics
 
Khaled Tolba
Employment - Foundation Medicine
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; Archer; ARIAD; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; EMD Serono; Foundation Medicine; Genentech; Gilead Sciences; Gritstone Bio; Hengrui Therapeutics; Instil Bio; Janssen Oncology; Maverick Therapeutics; Merck; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Panasonic; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)